Robot-Aided Diagnosis, Passive-Active Arm Motor and Sensory Rehabilitation Post Stroke: Aim 1

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Sensory and motor impairments following stroke can lead to substantial disability involving the arm and hand. The investigator hypothesized that excessive local and cross-coupled stiffness, diminished individuation and proprioceptive acuity will be present among multiple degree of freedom in the upper limb. The stiffness and spasticity will increase with time post-stroke. The objective of this study is to quantify the progression throughout the arm and hand during recovery from stroke. The investigator will measure the clinical assessment scores, and neuromechanical properties including range of motion, active and passive cross coupling, and spasticity by the IntelliArm robot.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: t
View:

• First focal unilateral lesion, ischemic or hemorrhagic

• Had a stroke less than a month prior to enrollment

• Rated between stages 1-4 on the Chedoke McMaster Stroke Assessment Impairment Inventory: Stage of Recovery of the Arm

• Rated between stages 1-4 on the Chedoke McMaster Stroke Assessment Impairment Inventory: Stage of Recovery of the Hand

Locations
United States
Maryland
University of Maryland, Baltimore
RECRUITING
Baltimore
Contact Information
Primary
Soh-Hyun Hur, B.S.
sohur@som.umaryland.edu
(410) 706-1625
Backup
Kyung Koh, Ph.D.
KKoh@som.umaryland.edu
(410) 706-8625
Time Frame
Start Date: 2018-05-07
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 56
Treatments
Healthy
Healthy volunteers with no history of neurological disorders
Stroke
Patients had a recent stroke, two weeks or earlier prior to enrollment
Authors
Derek Kamper
Sponsors
Collaborators: National Institute on Disability, Independent Living, and Rehabilitation Research, North Carolina State University
Leads: University of Maryland, Baltimore

This content was sourced from clinicaltrials.gov